comparemela.com

Latest Breaking News On - Stored cross site scripting - Page 4 : comparemela.com

openVIVA c2 20220101 Cross Site Scripting - KizzMyAnthia com

SEC Consult Vulnerability Lab Security Advisory < 20230925-0 >=======================================================================title: Stored Cross-Site Scriptingproduct: mb Support broker management solution openVIVA c2vulnerable version: fixed version: =>20220801CVE number: CVE-2022-39172impact: Mediumhomepage: https://mbsupport.defound: 2022-03-16by: Daniel Hirschberger (Office Bochum)SEC Consult Vulnerability LabAn integrated part of SEC Consult, an Eviden businessEurope | Asiahttps://www.sec-consult.com=======================================================================Vendor description: -"Support small and medium-sized companies as well as large corporate

WordPress Slimstat Analytics 5 0 9 Cross Site Scripting / SQL Injection

WordPress Newsletter 7 8 9 Cross Site Scripting

CSZ CMS 1 3 0 Cross Site Scripting - KizzMyAnthia com

# Exploit Title: CSZ CMS 1.3.0 - Stored Cross-Site Scripting (Plugin 'Gallery')# Date: 2023/08/18# CVE: CVE-2023-38911# Exploit Author: Daniel González# Vendor Homepage: https://www.cszcms.com/# Software Link: https://github.com/cskaza/cszcms# Version: 1.3.0# Tested on: CSZ CMS 1.3.0# Description:# CSZ CMS 1.3.0 is affected by a cross-site scripting (XSS) feature that allows attackers to execute arbitrary web scripts or HTML

User Registration And Login And User Management System 3 0 Cross Site Scripting

# Exploit Title: User Registration & Login and User Management System v3.0 - Stored Cross-Site Scripting (XSS)# Google Dork: NA# Date: 19/08/2023# Exploit Author: Ashutosh Singh Umath# Vendor Homepage: https://phpgurukul.com# Software Link: https://phpgurukul.com/user-registration-login-and-user-management-system-with-admin-panel/# Version: 3.0# Tested on: Windows 11# CVE : RequestedDescriptionUser Registration & Login and User Management System With admin panel 3.0 application from

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.